Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
42 participants
INTERVENTIONAL
2020-03-01
2022-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sleep Enhancement for Older Adults Living With Memory Loss And Their Care Partners
NCT06250725
Sleep Interventions and Neurocognitive Outcomes
NCT05987007
Multicomponent Behavioral Sleep Intervention for Insomnia in Older Adults With Mild Cognitive Impairment
NCT04364191
Use of an Internet-Based Insomnia Intervention to Prevent Cognitive Decline in Adults With Mild Cognitive Impairment
NCT04382365
Computer-Based Cognitive Training and Sleep Quality in Older Adult Insomniacs
NCT00901641
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cognitive Training
Computerized Cognitive Training
Cognitive Training
Participants (n=20) provided game console with cognitive training games and activities.
WLC
Waitlist Control
WLC (Waitlist Control)
Participants (n=20) will receive the cognitive training intervention later, following week 8 assessments.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cognitive Training
Participants (n=20) provided game console with cognitive training games and activities.
WLC (Waitlist Control)
Participants (n=20) will receive the cognitive training intervention later, following week 8 assessments.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No neurological or psychiatric illness, dementia, or loss of consciousness \> 5 mins.
* Nongamers (i.e. \<1 hour of video/cognitive training games per week over last 2 years)
* Proficient in English (reading and writing).
* Meet clinical diagnosis for Insomnia.
Insomnia:
* Insomnia complaints for 6+ months.
* Complaints occur despite adequate opportunity and circumstances for sleep.
* Consist of 1+ of the following: difficulty falling asleep, staying asleep, or waking up too early
* Daytime dysfunction (mood, cognitive, social, occupational) due to insomnia.
Exclusion Criteria
* Unable to undergo randomization.
* Cognitive impairments (i.e. mild cognitive impairment, dementia)
* Other sleep disorder (i.e., sleep apnea, Periodic Limb Movement Disorder)
* Severe untreated psychiatric comorbidity that renders randomization unethical
* Using psychotropic or other medications (e.g., beta-blockers) that alter sleep
* Uncorrected visual/auditory impairments
* Participation in nonpharmacological treatment for sleep/fatigue/mood outside the current study.
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
American Academy of Sleep Medicine
OTHER
University of Missouri-Columbia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ashley Curtis
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ashley Curtis, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Missouri- School of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Missouri
Columbia, Missouri, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018341
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.